Blue Bell Private Wealth Management’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $807K | Sell |
63,028
-541
| -0.9% | -$6.93K | 0.13% | 94 |
|
|
2025
Q1 | $807K | Buy |
63,569
+1,359
| +2% | +$17.2K | 0.15% | 91 |
|
|
2024
Q4 | $816K | Sell |
62,210
-507
| -0.8% | -$6.65K | 0.16% | 84 |
|
|
2024
Q3 | $946K | Buy |
62,717
+473
| +0.8% | +$7.13K | 0.18% | 80 |
|
|
2024
Q2 | $882K | Buy |
62,244
+30,750
| +98% | +$436K | 0.18% | 79 |
|
|
2024
Q1 | $429K | Buy |
31,494
+21,369
| +211% | +$291K | 0.09% | 122 |
|
|
2023
Q4 | $136K | Buy |
10,125
+3,811
| +60% | +$51.3K | 0.03% | 203 |
|
|
2023
Q3 | $78.7K | Hold |
6,314
| – | – | 0.02% | 219 |
|
|
2023
Q2 | $85.5K | Buy |
6,314
+4,900
| +347% | +$66.3K | 0.02% | 211 |
|
|
2023
Q1 | $19.7K | Sell |
1,414
-1,046
| -43% | -$14.6K | 0.01% | 321 |
|
|
2022
Q4 | $35K | Buy |
2,460
+635
| +35% | +$9.02K | 0.01% | 245 |
|
|
2022
Q3 | $25K | Sell |
1,825
-630
| -26% | -$8.63K | 0.01% | 273 |
|
|
2022
Q2 | $35K | Buy |
+2,455
| New | +$35K | 0.01% | 244 |
|
|
2021
Q1 | – | Sell |
-2,310
| Closed | -$50K | – | 175 |
|
|
2020
Q4 | $50K | Buy |
2,310
+701
| +44% | +$15.2K | 0.02% | 103 |
|
|
2020
Q3 | $28K | Hold |
1,609
| – | – | 0.01% | 113 |
|
|
2020
Q2 | $30K | Buy |
1,609
+509
| +46% | +$9.49K | 0.01% | 113 |
|
|
2020
Q1 | $16K | Buy |
1,100
+600
| +120% | +$8.73K | 0.01% | 129 |
|
|
2019
Q4 | $9K | Buy |
+500
| New | +$9K | ﹤0.01% | 158 |
|
|
2015
Q1 | – | Sell |
-2,219
| Closed | -$55K | – | 427 |
|
|
2014
Q4 | $55K | Sell |
2,219
-9,123
| -80% | -$226K | 0.03% | 214 |
|
|
2014
Q3 | $251K | Sell |
11,342
-26,552
| -70% | -$588K | 0.15% | 85 |
|
|
2014
Q2 | $787K | Buy |
37,894
+33,493
| +761% | +$696K | 0.48% | 36 |
|
|
2014
Q1 | $96K | Buy |
+4,401
| New | +$96K | 0.07% | 131 |
|